Nowakowski, G., King, R., Kearney, D., Bartlett, N., Kim, J., Fleury, I., Mollica, L., Portell, C., Yasenchak, C., Fenton, K., Hale, C., Hubbard, D., Lu, H., Patterson, M., Fanale, M., Rustia, E., Hahn, U. (2025). Efficacy of brentuximab vedotin combination treatment in patients with relapsed or refractory diffuse large B-cell lymphoma with CD30 <1% expression. Blood. https://doi.org/10.1182/blood-2025-1905